Home>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>Anisodamine

Anisodamine (Synonyms: 6-hydroxy Hyoscyamine)

Catalog No.GC17736

weak antagonist of α1-adrenoceptors

Products are for research use only. Not for human use. We do not sell to patients.

Anisodamine Chemical Structure

Cas No.: 55869-99-3

Size Price Stock Qty
10mg
$25.00
In stock
50mg
$69.00
In stock
250mg
$240.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Anisodamine is a natural tropane alkaloid shown to be a weak antagonist of α1-adrenoceptors, blocking WB-4101 and clonidine binding in brain membrane preparations with pKi values of 2.63 and 1.61, respectively.[1] Anisodamine also has antioxidant effects that may protect against free radical-induced cellular damage.[2] Anisodamine is predominantly found in the roots of A. tanguticus, which is used in traditional Chinese medicine for topical applications.[3]

Reference:
[1]. Varma, D.R., and Yue, T.L. Adrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of rats. British Journal of Pharmacology 87(3), 587-594 (1986).
[2]. Poupko, J.M., Baskin, S.I., and Moore, E. The pharmacological properties of anisodamine. Journal of Applied Toxicology 27(2), 116-121 (2007).
[3]. Ma, L., Gu, R., Tang, L., et al. Important poisonous plants in tβ ethnomedicine. Toxins (Basel) 7(1), 138-155 (2015).

Reviews

Review for Anisodamine

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Anisodamine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.